The Kinsunla reexam include a proposed modified dosing schedule. That is something that Anavex proposed and tested in the OLE. I would expect to be included in the reexam information. Then there is the "Additional analyses" that were included in the Kinsunla reexam. The ABCLEAR 2 & 3 analyses should fall under that same rule.
The reexam should have a CHMP decision 120 day after the request for reexam.
Market Data 
Markets 
AI
